Predictive Factors for Severe Thrombocytopenia and Classification of Causes of Thrombocytopenia in Premature Infants
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study investigated predictive factors for severe neonatal thrombocytopenia, which greatly increases the need for intensive care and is associated with a high mortality rate in premature infants. Factors adopted for prompt identification of at-risk newborns include blood test results and birth history. This study analyzed the relationship between the presence of severe neonatal thrombocytopenia and the mortality rate. The causes of thrombocytopenia in premature infants were also examined. Methods: This retrospective study evaluated 625 premature infants admitted to the neonatal intensive care unit (NICU) at Chung-Ang University Medical Center. The neonates were classified into 3 groups according to the severity of thrombocytopenia: mild (100×109/L≤platelet<150×109/L), moderate (50×109/L≤platelet<100×109/L), or severe (platelet<50×109/L). Analysis of blood samples obtained at the onset of thrombocytopenia included platelet count, white blood cell (WBC) count, hemoglobin level, hematocrit level, absolute neutrophil count, and high-sensitivity C-reactive protein level. Results: Of the 625 premature infants admitted to our NICU, 214 were detected with thrombocytopenia. The mortality rate in thrombocytopenic neonates was 18.2% (39/ 214), whereas a mortality rate of only 1.0% was observed in non-thrombocytopenic neonates. The major causes of thrombocytopenia were perinatal insufficiency and sepsis in premature infants. Severe thrombocytopenia was noted more frequently in premature infants with higher WBC counts and in those with a younger gestational age. Conclusion: Platelet count, WBC count, and gestational age are reliable predictors for severe neonatal thrombocytopenia. The major causes of thrombocytopenia were perinatal insufficiency and sepsis in premature infants.
Abstract
Purpose: This study investigated predictive factors for severe neonatal thrombocytopenia, which greatly increases the need for intensive care and is associated with a high mortality rate in premature infants. Factors adopted for prompt identification of at-risk newborns include blood test results and birth history. This study analyzed the relationship between the presence of severe neonatal thrombocytopenia and the mortality rate. The causes of thrombocytopenia in premature infants were also examined. Methods: This retrospective study evaluated 625 premature infants admitted to the neonatal intensive care unit (NICU) at Chung-Ang University Medical Center. The neonates were classified into 3 groups according to the severity of thrombocytopenia: mild (100×109/L≤platelet<150×109/L), moderate (50×109/L≤platelet<100×109/L), or severe (platelet<50×109/L). Analysis of blood samples obtained at the onset of thrombocytopenia included platelet count, white blood cell (WBC) count, hemoglobin level, hematocrit level, absolute neutrophil count, and high-sensitivity C-reactive protein level. Results: Of the 625 premature infants admitted to our NICU, 214 were detected with thrombocytopenia. The mortality rate in thrombocytopenic neonates was 18.2% (39/ 214), whereas a mortality rate of only 1.0% was observed in non-thrombocytopenic neonates. The major causes of thrombocytopenia were perinatal insufficiency and sepsis in premature infants. Severe thrombocytopenia was noted more frequently in premature infants with higher WBC counts and in those with a younger gestational age. Conclusion: Platelet count, WBC count, and gestational age are reliable predictors for severe neonatal thrombocytopenia. The major causes of thrombocytopenia were perinatal insufficiency and sepsis in premature infants.
참고문헌 (29)
- Pahal GS, "Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation", Am J Obstet Gynecol, 183, pp.1029~1034 (2000)[DOI]
- Burrows RF, "Incidentally detected thrombocytopenia in healthy mothers and their infants", N Engl J Med, 319, pp.142~145 (1988)[DOI]
- Sainio S, "Thrombocytopenia in term infants: a populationbased study", Obstet Gynecol, 95, pp.441~446 (2000)
- de Moerloose P, "Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay", Br J Haematol, 100, pp.735~740 (1998)[DOI]
- Burrows RF, "Fetal thrombocytopenia and its relation to maternal thrombocytopenia", N Engl J Med, 329, pp.1463~1466 (1993)[DOI]
- Uhrynowska M, "Neonatal and maternal thrombocytopenia: incidence and immune background", Eur J Haematol, 64, pp.42~46 (2000)[DOI]
- Dreyfus M, "Frequency of immune thrombocytopenia in newborns: a prospective study", Blood, 89, pp.4402~4406 (1997)
- Murray NA, "Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates", Pediatr Res, 40, pp.112~119 (1996)[DOI]
- Sola-Visner M, "New insights into the mechanisms of nonimmune thrombocytopenia in neonates", Semin Perinatol, 33, pp.43~51 (2009)[DOI]
- Murray NA, "Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients", Transfus Med, 12, pp.35~41 (2002)[DOI]
- Roberts I, "Thrombocytopenia in the neonate", Blood Rev, 22, pp.173~186 (2008)[DOI]
- Christensen RD, "Thrombocytopenia in small-for-gestational-age infants", Pediatrics, 136, pp.e361~e370 (2015)[DOI]
- Carr R, "Neonatal thrombocytopenia and platelet transfusion - a UK perspective", Neonatology, 107, pp.1~7 (2015)[DOI]
- Muthukumar P, "Severe thrombocytopenia and patterns of bleeding in neonates: results from a prospective observational study and implications for use of platelet transfusions", Transfus Med, 22, pp.338~343 (2012)[DOI]
- Arnold DM, "Positioning new treatments in the management of immune thrombocytopenia", Pediatr Blood Cancer, 60(Suppl 1), pp.S19~S22 (2013)[DOI]
- Wiedmeier SE, "Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system", J Perinatol, 29, pp.130~136 (2009)[DOI]
- Saxonhouse MA, "Reticulated platelet percentages in term and preterm neonates", J Pediatr Hematol Oncol, 26, pp.797~802 (2004)
- Fustolo-Gunnink SF, "Early onset thrombocytopenia in small for gestational age neonates: a retrospective cohort study", PLoS One, 11, pp.e0154853~ (2016)[DOI]
- Glass HC, "Outcomes for extremely premature infants", Anesth Analg, 120, pp.1337~1351 (2015)[DOI]
- Roberts I, "Neonatal thrombocytopenia: causes and management", Arch Dis Child Fetal Neonatal Ed, 88, pp.F359~F364 (2003)[DOI]
- Stanworth SJ, "Prospective, observational study of outcomes in neonates with severe thrombocytopenia", Pediatrics, 124, pp.e826~e834 (2009)[DOI]
- Valat AS, "Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia", Br J Haematol, 103, pp.397~401 (1998)[DOI]
- Baer VL, "Severe thrombocytopenia in the NICU", Pediatrics, 124, pp.e1095~e1100 (2009)[DOI]
- Tirupathi K, "Study of risk factors of neonatal thrombocytopenia", International Journal of Contemporary Pediatrics, 4, pp.191~ (2016)[DOI]
- Kamphuis MM, "Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review", Pediatrics, 133, pp.715~721 (2014)[DOI]
- Tighe P, "Severe thrombocytopenia in a neonate with congenital HIV infection", J Pediatr, 146, pp.408~413 (2005)[DOI]
- Beiner ME, "Risk factors for neonatal thrombocytopenia in preterm infants", Am J Perinatol, 20, pp.49~54 (2003)[DOI]
- Ohlin A, "Sepsis as a risk factor for neonatal morbidity in extremely preterm infants", Acta Paediatr, 104, pp.1070~1076 (2015)[DOI]
- Guida JD, "Platelet count and sepsis in very low birth weight neonates: is there an organism-specific response?", Pediatrics, 111, pp.1411~1415 (2003)[DOI]